TrialBlood transfusion = Trasfusione del sangue2020

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.

Annarita Tagliaferri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.